feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout",https://benzinga.com/general/biotech/21/11/24353731/the-daily-biotech-pulse-cumberland-jumps-on-fda-nod-regeneron-says-antibody-treatment-may-be-less,https://j.mp/3I6UKVp
